Brief: Sorrento Announces Publication Of Pivotal Trial Results Of Non-Small Cell Lung Cancer Treatment
12/11/2021 14:16
Nov 12 (Reuters) - Sorrento Therapeutics Inc SRNE.O :
* SORRENTO ANNOUNCES PUBLICATION OF SIGNIFICANT POSITIVE
PIVOTAL
TRIAL RESULTS OF ABIVERTINIB FOR THE TREATMENT OF NON-SMALL CELL
LUNG CANCER (NSCLC) IN THE PEER-REVIEWED JOURNAL CLINICAL CANCER
RESEARCH
Source text for Eikon: ID:nGNX1rfnzd
Further company coverage: SRNE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sorrento Therapeutics
See all newsBrief: Scilex Holding Says US Bankruptcy Court Extended Lockup Period On Shares Of Scilex Stock
Company's PO box allows it to file for bankruptcy in Texas, judge rules
Latham, Jackson Walker avoid sanctions over bankruptcy forum shopping dispute (updated)
Latham, Jackson Walker avoid sanctions over bankruptcy forum shopping dispute
Brief: Sorrento Therapeutics Reduced U.S. Headcount From 215 To 128 on Sept. 20